{"id":32586,"date":"2024-10-22T19:11:52","date_gmt":"2024-10-22T16:11:52","guid":{"rendered":"https:\/\/umfst.ro\/?post_type=program-de-studiu&#038;p=32586"},"modified":"2026-09-18T12:56:12","modified_gmt":"2026-09-18T09:56:12","slug":"medicamentul-de-la-uz-la-abuz-farmacovigilenta-si-reglementare","status":"publish","type":"program-de-studiu","link":"https:\/\/umfst.ro\/hu\/program-de-studiu\/farmacie\/medicamentul-de-la-uz-la-abuz-farmacovigilenta-si-reglementare\/","title":{"rendered":"Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><strong>Nivelul de studii: <\/strong>Studii universitare de masterat (nivelul 7 EQF\/CEC \u0219i CNC)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Domeniul fundamental:<\/strong> \u0218tiin\u021be biologice \u0219i biomedicale<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Domeniul de studii:<\/strong> Gy\u00f3gyszer\u00e9szet<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Programul de studii:<\/strong> Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Denumirea calific\u0103rii:<\/strong> Asistent de cercetare \u00een farmacovigilen\u021b\u0103<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Obiectivele form\u0103rii \u00een masteratul Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare reprezint\u0103<br><\/strong>Formarea de speciali\u0219ti \u00een domeniul farmacovigilen\u021bei \u0219i al studiilor clinice care implic\u0103 medicamentul, speciali\u0219ti care vor aduce beneficii sistemului medical printr-o implicare activ\u0103 \u00een monitorizarea eficacit\u0103\u021bii \u0219i siguran\u021bei farmacoterapiei, evaluarea critic\u0103 a intoxica\u021biilor medicamentoase, identificarea \u0219i raportarea reac\u021biilor adverse, elaborarea unor planuri de reducere a consumului abuziv de substan\u021be, respectiv de optimizare a terapiei pe criteriu farmacocinetic, clinic \u0219i paraclinic. Formarea profesional\u0103 va fi asigurat\u0103 de speciali\u0219ti \u00een domeniul farmacologiei, toxicologiei, analizei de laborator, precum \u0219i din domeniile conexe ale legisla\u021biei aplicabile (drept).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cencep\u00e2nd din anul universitar 2023-2024, masteranzii, cu sprijinul companiei Astra Zeneca, vor avea posibilitatea de a efectua stagiul practic \u00een cadrul Centrului de excelen\u021b\u0103 \u00een farmacovigilen\u021b\u0103 din T\u00e2rgu Mure\u0219.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kiknek sz\u00f3l:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Absolven\u021bilor Facult\u0103\u021bii de Medicin\u0103<\/li>\n\n\n\n<li>Absolven\u021bilor Facult\u0103\u021bii de Farmacie<\/li>\n\n\n\n<li>Speciali\u0219tilor care provin din mediu socio-economic (industrie farmaceutic\u0103, organisme cu atribu\u021bii de reglementare \u0219i control a medicamentului \u0219i suplimentelor alimentare) \u015fi care justific\u0103 cuno\u015ftin\u0163e de baz\u0103 \u00een specialit\u0103\u0163ile abordate prin masterat.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Nivelul de studii: Studii universitare de masterat (nivelul 7 EQF\/CEC \u0219i CNC) Domeniul fundamental: \u0218tiin\u021be biologice \u0219i biomedicale Domeniul de studii: Farmacie Programul de studii: Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare Denumirea calific\u0103rii: Asistent de cercetare \u00een farmacovigilen\u021b\u0103 Obiectivele form\u0103rii \u00een masteratul Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare reprezint\u0103Formarea [&hellip;]<\/p>\n","protected":false},"author":25,"featured_media":37501,"menu_order":10,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"24241,28188,23091,23473,21900,26081","_relevanssi_noindex_reason":"Rank Math Relevanssi index exclude","footnotes":""},"facultatea":[220],"class_list":["post-32586","program-de-studiu","type-program-de-studiu","status-publish","format-standard","has-post-thumbnail","hentry","facultatea-farmacie"],"meta_box":{"perspective_educationale_hu":"","competente_cunostinte_hu":"","durata_hu":"1 \u00e9v","number_b423w5447l":"","forma_de_educatie_hu":"Frekvenci\u00e1val","limba_de_predare_hu":"Rom\u00e1n","programul_de_studii_hu":"Akkredit\u00e1lt","ciclul_de_studii":"Masterat","extras_hu":"","descriere_hu":"","titlul_programului_hu":"","plans_educatifs":["<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2026-2027\/PI_MFR_2026-2027.pdf\">2026 - 2027<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2025-2026\/Plan_invatamant_MFR_2025-2026.pdf\">2025 - 2026<\/a><\/p>\n"],"competences_et_connaissances_acquises":"<p><strong>Industrie pharmaceutique<\/strong><\/p>\n<p><strong>- Sp\u00e9cialiste en pharmacovigilance<\/strong><\/p>\n<ul>\n<li>Surveillance et \u00e9valuation des effets ind\u00e9sirables des m\u00e9dicaments, avec signalement aux autorit\u00e9s de r\u00e9gulation<\/li>\n<li>Assurance de la conformit\u00e9 r\u00e9glementaire et gestion des risques li\u00e9s aux m\u00e9dicaments<\/li>\n<li>Contribution aux strat\u00e9gies de minimisation des risques<\/li>\n<\/ul>\n<p><strong>- Analyste de donn\u00e9es en pharmacovigilance<\/strong><\/p>\n<ul>\n<li>Travail sur les bases de donn\u00e9es pour identifier les signaux de s\u00e9curit\u00e9 et les tendances<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Institutions de r\u00e9gulation et de sant\u00e9 publique<\/strong><\/p>\n<ul>\n<li>Analyse les donn\u00e9es de s\u00e9curit\u00e9 des m\u00e9dicaments et assure la conformit\u00e9 r\u00e9glementaire des produits m\u00e9dicinaux.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Recherche et d\u00e9veloppement<\/strong><\/p>\n<ul>\n<li>Chercheur en pharmaco\u00e9pid\u00e9miologie<\/li>\n<li>\u00c9tude de l\u2019utilisation et des effets des m\u00e9dicaments dans de larges populations<\/li>\n<\/ul>\n<p><strong>- Consultant en pharmacovigilance<\/strong><\/p>\n<ul>\n<li>Conseil aux entreprises pharmaceutiques et institutions sur les strat\u00e9gies de s\u00e9curit\u00e9 des m\u00e9dicaments<\/li>\n<\/ul>\n","duree":"2 ans","credits":"120","forme_d_education":"Avec fr\u00e9quence","langue_d_enseignement":"Roumain","programme_d_etudes":"Accr\u00e9dit\u00e9","chiffres_de_l_education":"","cycle_d_etudes":"Master","xtrait":"","descriptionFR":"<p><strong>Niveau d\u2019\u00e9tudes<\/strong> : Master (niveau 7 EQF\/CEC et CNC)<br \/><strong>Domaine fondamental<\/strong> : Sciences biologiques et biom\u00e9dicales<br \/><strong>Domaine d\u2019\u00e9tudes<\/strong> : Pharmacie<br \/><strong>Programme d\u2019\u00e9tudes<\/strong> : M\u00e9dicaments, de l\u2019usage \u00e0 l\u2019abus. Pharmacovigilance et r\u00e9glementation<br \/><strong>Qualification<\/strong> : Assistant de recherche en pharmacovigilance<\/p>\n<p>L\u2019objectif du programme de master \u00ab M\u00e9dicaments, de l\u2019usage \u00e0 l\u2019abus. Pharmacovigilance et r\u00e9glementation \u00bb est la formation de sp\u00e9cialistes dans le domaine de la pharmacovigilance et des essais cliniques impliquant des m\u00e9dicaments, capables d\u2019am\u00e9liorer le syst\u00e8me m\u00e9dical par une implication active dans la surveillance de l\u2019efficacit\u00e9 et de la s\u00e9curit\u00e9 de la pharmacoth\u00e9rapie, l\u2019\u00e9valuation critique des intoxications m\u00e9dicamenteuses, l\u2019identification et la d\u00e9claration des effets ind\u00e9sirables, l\u2019\u00e9laboration de plans de r\u00e9duction de l\u2019usage abusif des substances et l\u2019optimisation des traitements selon des crit\u00e8res pharmacocin\u00e9tiques, cliniques et paracliniques. La formation professionnelle est assur\u00e9e par des sp\u00e9cialistes en pharmacologie, toxicologie, analyse de laboratoire et domaines connexes du droit (l\u00e9gislation applicable).<\/p>\n<p>\u00c0 partir de l\u2019ann\u00e9e acad\u00e9mique 2023\u20132024, les \u00e9tudiants de master, avec le soutien d\u2019AstraZeneca, auront la possibilit\u00e9 d\u2019effectuer une formation pratique au Centre d\u2019excellence en pharmacovigilance de Targu Mures.<\/p>\n","titre_du_programme":"M\u00e9dicaments, de l\u2019usage \u00e0 l\u2019abus. Pharmacovigilance et r\u00e9glementation","calendareledisciplinelor":"","facultatea":"Farmacie","link-facultate":"https:\/\/umfst.ro\/facultatea-de-farmacie\/","activare_buton":"0","link_aplica_acum":"https:\/\/admitere.umfst.ro\/","select_msvroae1e1i":"2 ani","credite":"120","forma_de_invatamant":"Cu frecven\u021b\u0103","limba_de_predare":"Rom\u00e2n\u0103","progam_de_studiu":"Acreditat","cifra_de_scolarizare":"","wysiwyg_k17cu8f0jhs":"<p>Cre\u0219terea consumului de medicamente la nivel mondial implic\u0103 o evaluare atent\u0103 nu doar a necesit\u0103\u021bii utiliz\u0103rii medicamentelor, ci \u0219i a riscurilor care apar, mai ales \u00een cazul unui consum abuziv. \u00cen cadrul programului de studii de masterat <em>Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare <\/em>vor fi abordate aspecte teoretice \u0219i practice referitoare la utilizarea substan\u021belor cu autoriza\u021bie de punere de pia\u021b\u0103 din punct de vedere toxicologic (intoxica\u021bii medicamentoase acute \u0219i cronice, utilizare abuziv\u0103) \u0219i al siguran\u021bei medicamentoase (supradozare \u0219i managementul intoxica\u021biilor, siguran\u021ba utiliz\u0103rii la pacien\u021bii pediatrici\/ geriatrici, siguran\u021ba utiliz\u0103rii \u00een sarcin\u0103 \u0219i al\u0103ptare). Masteranzii vor dob\u00e2ndi \u0219i cuno\u0219tin\u021be legate de statutul medicamentelor, consecin\u021bele legale ale de\u021binerii, comercializ\u0103rii \u0219i consumului anumitor clase terapeutice precum \u0219i despre metodele de recoltare \u0219i analiz\u0103 a probelor biologice \u00een vederea stabilirii cazurilor de utilizare abuziv\u0103 (dependen\u021b\u0103, dopaj) sau \u00een scop suicidar\/ criminal.<\/p>\n<p>Programul de studii postuniversitare de masterat Medicamentul de la uz la abuz. Farmacovigilen\u021b\u0103 \u0219i reglementare reprezint\u0103 primul program de master care \u00eembin\u0103, pe parcursul a doi ani de preg\u0103tire, no\u021biuni de:<\/p>\n<ul>\n<li>siguran\u021b\u0103 medicamentoas\u0103 la popula\u021bia general\u0103, precum \u0219i la popula\u021bii speciale de pacien\u021bi (v\u00e2rstnici, pediatrici, femei \u00eens\u0103rcinate sau care al\u0103pteaz\u0103),<\/li>\n<li>toxicologie, utilizare abuziv\u0103 a medicamentelor \u00een scop suicidar, criminal sau de dopaj,<\/li>\n<li>recoltare \u0219i analiz\u0103 a probelor biologice \u00een scopul identific\u0103rii cazurilor de utilizare medicamentoas\u0103 abuziv\u0103,<\/li>\n<li>legisla\u021bie farmaceutic\u0103<\/li>\n<\/ul>\n","wysiwyg_5t0s3p61prl":"<p><strong>Obiectivul general<\/strong> al programului de studii const\u0103 \u00een formarea profesional\u0103 a unui grup de speciali\u0219ti \u00een concordan\u021b\u0103 cu cerin\u021bele actuale din Rom\u00e2nia \u0219i Uniunea European\u0103 prin asigurarea unui standard ridicat de preg\u0103tire teoretic\u0103 \u0219i practic\u0103 conforme profilului competen\u021belor impuse \u00een exercitarea profesiilor din domeniul medical \u00een spa\u021biul european.<\/p>\n<p><strong>Obiective specifice:<\/strong><\/p>\n<p>1. Dob\u00e2ndirea capacit\u0103\u021bii de a evalua eficacitatea \u0219i siguran\u021ba tratamentului medicamentos, respectiv de a identifica \u0219i raporta reac\u021bii adverse medicamentoase ap\u0103rute ca urmare a:<\/p>\n<ul>\n<li>utiliz\u0103rii substan\u021belor conform indica\u021biilor terapeutice,<\/li>\n<li>utiliz\u0103rii substan\u021belor \u00een alte scopuri dec\u00e2t cele terapeutice (<em>off-label<\/em>, recrea\u021bional, dopaj) sau la doze supraterapeutice\/ toxice (omucidere, suicid),<\/li>\n<li>utiliz\u0103rii substan\u021belor la pacien\u021bii cu v\u00e2rste extreme (pacien\u021bi pediatrici \u0219i geriatrici),<\/li>\n<li>utiliz\u0103rii substan\u021belor \u00een timpul sarcinii \u0219i al\u0103pt\u0103rii.<\/li>\n<\/ul>\n<p>2. Dezvoltarea capacit\u0103\u021bii de elaborare a unui plan de supraveghere post-marketing.<\/p>\n<p>3. Dezvoltarea capacit\u0103\u021bii de elaborare unui plan de reducere a consumului abuziv de substan\u021be.<\/p>\n<p>4. Dob\u00e2ndirea de cuno\u0219tin\u021be \u00een vederea elabor\u0103rii de rapoarte cu scopul de a optimiza ghidurile terapeutice \u00een vigoare.<\/p>\n<p>5. Dob\u00e2ndirea de cuno\u0219tin\u021be \u00een vederea elabor\u0103rii unui plan de ajustare a posologiei la pacien\u021bii pediatrici \u0219i geriatrici.<\/p>\n<p>6. Dob\u00e2ndirea de cuno\u0219tin\u021be necesare identific\u0103rii posibilelor metode de combatere a intoxica\u021biilor medicamentoase (acute \u0219i\/sau cronice), precum \u0219i elabor\u0103rii de scheme de tratament sau identificarea \u0219i propunerea de substan\u021be antidot.<\/p>\n<p>7. Dezvoltarea capacit\u0103\u021bii de elaborare a unor procedee \u015fi tehnici pentru determinarea cantitativ\u0103 \u0219i identificarea substan\u0163elor medicamentoase, respectiv de \u00eembun\u0103t\u0103\u021bire a proceselor de prelevare \u015fi de preg\u0103tire preliminar\u0103 a probelor biologice.<\/p>\n","wysiwyg_qifse9n3mh":"<p><strong>Competen\u021be profesionale<\/strong><\/p>\n<ul>\n<li>Identificarea \u0219i prevenirea unor efecte nocive care pot s\u0103 apar\u0103 ca urmare a utiliz\u0103rii medicamentelor \u00een indica\u021biile prev\u0103zute \u00een rezumatul caracteristicilor produsului (RCP),<\/li>\n<li>Identificarea \u0219i prevenirea unor efecte nocive care pot s\u0103 apar\u0103 ca urmare a utiliz\u0103rii medicamentelor \u00een alte scopuri dec\u00e2t cele terapeutice (utilizare <em>off-label<\/em>, doping, omucidere, suicid),<\/li>\n<li>Consultan\u021b\u0103 \u0219i expertiz\u0103 cu privire la utilizarea medicamentelor \u00een condi\u021bii de eficacitate \u0219i siguran\u021b\u0103 la pacien\u021bi de toate v\u00e2rstele (copii, adul\u021bi, v\u00e2rstnici),<\/li>\n<li>Consultan\u021b\u0103 \u0219i expertiz\u0103 cu privire la utilizarea medicamentelor \u00een condi\u021bii de eficacitate \u0219i siguran\u021b\u0103 \u00een timpul sarcinii \u0219i al\u0103pt\u0103rii,<\/li>\n<li>Consultan\u021b\u0103 \u0219i expertiz\u0103 \u00een cazuri de utilizare abuziv\u0103 a medicamentelor \u0219i managementul intoxica\u021biilor medicamentoase \u0219i a deturn\u0103rii medicamentului (dopaj, trafic, utilizare \u00een scop criminal).<\/li>\n<li>Recoltarea \u0219i analiza probelor biologice.<\/li>\n<\/ul>\n<p><strong>Competen\u0163e transversale<\/strong><\/p>\n<ul>\n<li>Identificarea obiectivelor de realizat a resurselor disponibile, condi\u021biilor de finalizare a etapelor \u0219i timpilor de lucru, termenelor de realizare aferente \u0219i riscurilor aferente,<\/li>\n<li>Aplicarea de tehnici de relat\u0326ionare s\u0326i munca\u0306 eficienta\u0306 i\u0302n cadrul echipei,<\/li>\n<li>Utilizarea eficient\u0103 a surselor informa\u021bionale \u0219i a resurselor de comunicare \u0219i formare profesional\u0103 asistat\u0103.<\/li>\n<\/ul>\n","textarea_ywu170mmtv":"<ol>\n<li><strong>Industria farmaceutic\u0103:<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Specialist \u00een farmacovigilen\u021b\u0103<br \/><\/strong>\n<ul>\n<li>Monitorizeaz\u0103 \u0219i evalueaz\u0103 efectele adverse ale medicamentelor, raport\u00e2ndu-le autorit\u0103\u021bilor;<\/li>\n<li>Asigur\u0103 conformitatea cu reglement\u0103rile \u0219i gestioneaz\u0103 riscurile medicamentelor;<\/li>\n<li>Contribuie la dezvoltarea \u0219i implementarea strategiilor de minimizare a riscurilor.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li><strong>Analist date de farmacovigilen\u021b\u0103<\/strong>\n<ul>\n<li>Lucreaz\u0103 cu baze de date pentru a identifica semnale de siguran\u021b\u0103 \u0219i tendin\u021be.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ol start=\"2\">\n<li><strong>Institu\u021bii de reglementare \u0219i s\u0103n\u0103tate public\u0103:<\/strong><\/li>\n<\/ol>\n<ul>\n<li>Analizeaz\u0103 datele de siguran\u021b\u0103 \u0219i asigur\u0103 conformitatea medicamentelor.<\/li>\n<\/ul>\n<ol start=\"3\">\n<li><strong>Cercetare \u0219i dezvoltare:<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Cercet\u0103tor \u00een domeniul farmacoepidemiologiei<\/strong>\n<ul>\n<li>Studiaz\u0103 utilizarea \u0219i efectele medicamentelor \u00een popula\u021bii mari.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Consultant \u00een farmacovigilen\u021b\u0103<\/strong>\n<ul>\n<li>Consiliaz\u0103 companiile farmaceutice \u0219i institu\u021biile \u00een strategiile de siguran\u021b\u0103.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n","coordonator":"prof. univ. dr. Camil-Eugen Vari","email_rho5k00rj2a":"camil.vari@umfst.ro","pagina_de_facebook":"","pagina_de_instagram":"","file_upload_v1oldkq15g":["<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2026-2027\/PI_MFR_2026-2027.pdf\">2026 - 2027<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2025-2026\/Plan_invatamant_MFR_2025-2026.pdf\">2025 - 2026<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2024-2025\/Plan_invatamant_MFR_2024_2026.pdf\">2024 - 2025<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/master\/Planuri\/2023-2024\/FF\/Plan%20de%20%C3%AEnv%C4%83%C8%9B%C4%83m%C3%A2nt%20MFR%202023-2025.pdf\">2023 - 2024<\/a><\/p>\n"],"fiseledisciplinelorbuton":[],"program-title":"Drugs from Use to Abuse. Pharmacovigilance and Regulation","wysiwyg_7dnkh9v375k":"<p><strong>Studies level: <\/strong>Master\u2019s degree (level 7 EQF\/CEC and CNC)<\/p>\n<p><strong>Broad field:<\/strong> Biological and biomedical sciences<\/p>\n<p><strong>Study field:<\/strong> Pharmacy<\/p>\n<p><strong>Study program:<\/strong> Drugs from use to abuse. Pharmacovigilance and regulation<\/p>\n<p><strong>Qualification:<\/strong> Pharmacovigilance Research Assistant<\/p>\n<p class=\" translation-block\">The objective of the Drugs from use to abuse. Pharmacovigilance and regulation Master's degree program is the training of specialists in the field of pharmacovigilance and clinical trials involving drugs, specialists who will improve the medical system through active involvement in monitoring the efficacy and safety of pharmacotherapy, critical assessment of drug intoxications, identification and reporting of adverse reactions, development of substance misuse reduction plans and optimization of therapy on pharmacokinetic, clinical and paraclinical criteria. Professional training will be provided by specialists in the fields of pharmacology, toxicology, laboratory analysis and related areas of applicable legislation (law).<\/p>\n<p>Starting with the academic year 2023-2024, the master's students, supported by Astra Zeneca, will have the opportunity to carry out a practical training at the Pharmacovigilance Centre of Excellence in T\u00e2rgu Mure\u0219.<\/p>\n<p><strong>Who is it for? <\/strong><\/p>\n<ul>\n<li>Graduates of the Faculty of Medicine<\/li>\n<li>Graduates of the Faculty of Pharmacy<\/li>\n<li>Specialists coming from a socio-economic background (pharmaceutical industry, regulatory and control authorities for medicinal products and food supplements) who can justify basic knowledge in the specialties covered by the Master's degree.<\/li>\n<\/ul>\n","excerpt-en":"","duration":"2 years","form_of_education":"With frequency","language_of_instruction":"Romanian","study_program":"Accredited","education_figures":"","cycle_of_studies":"Master's","acquired_skills_and_knowledge":"<p><strong>Professional competencies<\/strong><\/p>\n<ul>\n<li>The identification and prevention of adverse effects which may occur as a result of the use of medicinal products in the indications set out in the summary of product characteristics (SPC),<\/li>\n<li class=\" translation-block\">The identification and prevention of adverse effects which may arise from the use of medicinal products for non-therapeutic purposes (off-label use, doping, homicide, suicide),<\/li>\n<li>The provision of consultancy and expertise on the safe and effective use of medicines in patients of all ages (children, adults, elderly),<\/li>\n<li>The provision of consultancy and expertise on the safe and effective use of medicines during pregnancy and breastfeeding,<\/li>\n<li>The provision of consultancy and expertise in cases of misuse of medicines and management of drug intoxication and drug misappropriation (doping, trafficking, criminal use).<\/li>\n<li>The collection and analysis of biological samples.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Transversal competencies<\/strong><\/p>\n<ul>\n<li>The identification of the objectives to be achieved, of the resources available, of the conditions for their completion, of the phasing and timing of the work, of the respective deadlines and of the associated risks;<\/li>\n<li>The application of techniques and interpersonal skills for effective teamwork;<\/li>\n<li>The effective use of information sources and communication and assisted training resources.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<div class=\"elementor-element elementor-element-155306c elementor-widget elementor-widget-heading\" data-id=\"155306c\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n<div class=\"elementor-widget-container\">\n<p class=\"elementor-heading-title elementor-size-default\"><strong>Occupational prospects<\/strong><\/p>\n<\/div>\n<\/div>\n<div class=\"elementor-element elementor-element-91de08a elementor-widget elementor-widget-text-editor\" data-id=\"91de08a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n<div class=\"elementor-widget-container\">\n<ol>\n<li><strong>Pharmaceutical Industry<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Pharmacovigilance Specialist<br \/><\/strong>\n<ul>\n<li>Monitors and evaluates adverse drug reactions, reporting them to regulatory authorities;<\/li>\n<li>Ensures compliance with regulatory requirements and manages drug-related risks;<\/li>\n<li>Contributes to the development and implementation of risk minimization strategies.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li><strong>Pharmacovigilance Data Analyst<\/strong>\n<ul>\n<li>Works with databases to identify safety signals and trends.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ol start=\"2\">\n<li><strong>Regulatory and Public Health Institutions<\/strong><\/li>\n<\/ol>\n<ul>\n<li>Analyzes drug safety data and ensures regulatory compliance for medicinal products.\n<p>&nbsp;<\/p>\n<\/li>\n<\/ul>\n<ol start=\"3\">\n<li><strong>Research and Development<\/strong><\/li>\n<\/ol>\n<ul>\n<li><strong>Pharmacoepidemiology Researcher<\/strong>\n<ul>\n<li>studies the use and effects of medications in large populations.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Pharmacovigilance Consultant<\/strong>\n<ul>\n<li>advises pharmaceutical companies and institutions on drug safety strategies.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n","educational_plans":["<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2026-2027\/PI_MFR_2026-2027.pdf\">2026 - 2027<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2025-2026\/Plan_invatamant_MFR_2025-2026.pdf\">2025 - 2026<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/f_farmacie\/Planuri_de_invatamant\/2024-2025\/Curriculum_MFR_2024_2026.pdf\">2024 - 2025<\/a><\/p>\n","<p><a href=\"https:\/\/www.umfst.ro\/fileadmin\/master\/Planuri\/2023-2024\/FF\/Plan%20de%20%C3%AEnv%C4%83%C8%9B%C4%83m%C3%A2nt%20MFR%202023-2025.pdf\">2023 - 2024<\/a><\/p>\n"]},"_links":{"self":[{"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/program-de-studiu\/32586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/program-de-studiu"}],"about":[{"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/types\/program-de-studiu"}],"author":[{"embeddable":true,"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/comments?post=32586"}],"version-history":[{"count":1,"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/program-de-studiu\/32586\/revisions"}],"predecessor-version":[{"id":50306,"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/program-de-studiu\/32586\/revisions\/50306"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/media\/37501"}],"wp:attachment":[{"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/media?parent=32586"}],"wp:term":[{"taxonomy":"facultatea","embeddable":true,"href":"https:\/\/umfst.ro\/hu\/wp-json\/wp\/v2\/facultatea?post=32586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}